Literature DB >> 31720806

Improved Local Tumor Control and Survival Rates by Obtaining a 3D-Safety Margin in Superselective Transarterial Chemoembolization for Small Hepatocellular Carcinoma.

Thanate Kattipatanapong1,2, Hideyuki Nishiofuku3, Toshihiro Tanaka1, Takeshi Sato1, Tetsuya Masada1, Shota Tatsumoto1, Takeshi Matsumoto1, Kimihiko Kichikawa1.   

Abstract

OBJECTIVE: To investigate technical factors affecting local tumor control of small hepatocellular carcinoma (HCC) treated by superselective conventional transarterial chemoembolization (cTACE) using lipiodol and to compare prognoses between groups with and without these factors.
MATERIALS AND METHODS: Sixty-three consecutive patients with 73 HCC nodules (diameter, 1-3 cm) treated by cTACE were retrospectively analyzed. A positive or a negative 3D-safety margin was defined as a ≥ 1-mm area of lipiodol accumulation or as a diameter of lipiodol accumulation < 1 mm in liver parenchyma surrounding the tumor using plain CT images obtained within a week after TACE. Uni- and multivariate analyses were performed to identify technical factors determining local tumor control rate. Subgroup analysis of survival rates in treatment-naïve patients was performed according to the detected factors.
RESULTS: In univariate analyses, three-dimensional (3D)-safety margin and portal vein visualization were associated with local tumor control rates. In multivariate analysis, only positive 3D-safety margin remained a significant contributor (p = 0.001). Two-year cumulative local disease-free survival rates with positive and negative 3D-safety margin were 82.8% and 19.3%, respectively (p = 0.001). In subgroup survival analysis of the 36 newly diagnosed patients, the 1-, 2-, 3-, 4-, and 5-year cumulative OS rates for patients with and without positive margins were 100% versus 100%, 96.4% versus 75.0%, 81.8% versus 62.5%, 74.4% versus 41.7%, and 47.0% versus 0%, respectively (median survival time; 57.6 months vs. 37.1, p = 0.047).
CONCLUSION: Obtaining a 3D-safety margin can suppress local tumor recurrence and prolong survival in superselective cTACE for small HCC.

Entities:  

Keywords:  Ethiodized oil; Hepatocellular carcinoma; Prognosis; Recurrence; Three-dimensional safety margin; Transarterial chemoembolization

Year:  2019        PMID: 31720806     DOI: 10.1007/s00270-019-02365-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Feasibility and Techniques of Securing 3D-Safety Margin in Superselective Transarterial Chemoembolization to Improve Local Tumor Control for Small Hepatocellular Carcinoma: An Intend-to-Treat Analysis.

Authors:  Ching Charoenvisal; Toshihiro Tanaka; Hideyuki Nishiofuku; Hiroshi Anai; Takeshi Sato; Takeshi Matsumoto; Nagaaki Marugami; Kimihiko Kichikawa
Journal:  Liver Cancer       Date:  2021-01-12       Impact factor: 11.740

2.  Hepatocellular carcinoma with type II-III portal vein tumour thrombosis: treatment using transarterial chemoembolisation and microwave ablation.

Authors:  Wen Peng Zhao; Honglu Li; Jiang Guo; Liang Cai; Youjia Duan; Xiaopu Hou; Hongliu Du; Xihong Shao; Zhenying Diao; Changqing Li
Journal:  Br J Radiol       Date:  2020-11-27       Impact factor: 3.039

3.  Comparison of local recurrence in transcatheter arterial chemoembolization of hepatocellular carcinoma with or without accumulation of iodized oil beyond corona enhancement area: Short-term results.

Authors:  Yukinobu Watanabe; Masahiro Ogawa; Masahiro Kaneko; Mariko Kumagawa; Midori Hirayama; Naoki Matsumoto; Hiroshi Nakagawara; Toshiki Yamamoto; Mitsuhiko Moriyama
Journal:  Radiol Oncol       Date:  2021-12-22       Impact factor: 2.991

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.